Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Second Price Monitoring Extn

January 5, 2021
RNS Number : 6755K Renalytix AI PLC 05 January 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension

Price Monitoring Extension

January 5, 2021
RNS Number : 6733K Renalytix AI PLC 05 January 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Partnership Between RenalytixAI and DaVita

January 5, 2021
RNS Number : 5211K Renalytix AI PLC 05 January 2021   This announcement contains inside information   Renalytix AI plc (" RenalytixAI " or the " Company ")   Early Risk Identification at Core of Innovative Kidney Care Partnership Between RenalytixAI, DaVita   First-of-its-kind program combines

RENX to present at 39th JP Morgan Healthcare Conf.

January 4, 2021
RNS Number : 3438K Renalytix AI PLC 04 January 2021     Renalytix AI plc (" RenalytixAI " or the " Company ")   RenalytixAI to Present at the 39 th Annual J.P. Morgan Healthcare Conference     NEW YORK , 4 January 2021 - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial

Result of AGM

December 7, 2020
RNS Number : 8167H Renalytix AI PLC 07 December 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   Result of AGM   Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney

Partnership with National Kidney Foundation

December 2, 2020
RNS Number : 3041H Renalytix AI PLC 02 December 2020   Renalytix AI plc (" RenalytixAI " or the " Company ")   Partnership with National Kidney Foundation   to improve management of Early Stage Kidney Disease   Program focused on improving disease management and outcomes beginning at the primary

Holding(s) in Company

November 26, 2020
RNS Number : 5461G Renalytix AI PLC 26 November 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing

Second Price Monitoring Extn

November 25, 2020
RNS Number : 5327G Renalytix AI PLC 25 November 2020   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension
Displaying 21 - 30 of 169